Gastrointestinal varices epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Overview
Gastroesophageal varices are present in approximately 50,000 per 100,000 patients with cirrhosis, depending upon the clinical stage of the disease. The annual incidence of gastrointestinal varices ranges from a low of 7,000 per 100,000 individuals to a high of 8,000 per 100,000 individuals. Variceal hemorrhage occurs at a rate of around 10%-15% per year and depends on the severity of liver disease, size of varices, and presence of red wale marks (areas of thinning of the variceal wall).
Epidemiology and Demographics
Epidemiology and Demographics
Prevalence
- Gastroesophageal varices are present in approximately 50,000 per 100,000 patients with cirrhosis, depending upon the clinical stage of the disease[1]
- In patients with compensated cirrhosis, gastroesophageal varices are present in 30,000 – 40,000 patients per 100,000 patients, whereas they can be present in up to 85,000 per 100,000 patients with decompensated cirrhosis[2]
Incidence
- The annual incidence of gastrointestinal varices ranges from a low of 7,000 per 100,000 individuals to a high of 8,000 per 100,000 individuals[3]
- Progression from small varices to large varices occurs at a rate of 10%- 12% annually[4]
- Variceal hemorrhage occurs at a rate of around 10%-15% per year and depends on the severity of liver disease, size of varices, and presence of red wale marks (areas of thinning of the variceal wall)[5][6]
Age
- African Americans are significantly more likely to be older than Caucasians or Hispanics, when patients with cirrhosis are studied[7]
- White patients have equal proportions of cirrhotics in the younger and older age groups[8]
Race
References
References
- ↑ “Portal hypertension and variceal bleeding: An AASLD single topic symposium – Grace – 2003 – Hepatology – Wiley Online Library”.
- ↑ Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A (2007). “Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database”. Gastrointest. Endosc. 65 (1): 82–8. doi:10.1016/j.gie.2006.08.023. PMID 17185084.
- ↑ Groszmann, Roberto J.; Garcia-Tsao, Guadalupe; Bosch, Jaime; Grace, Norman D.; Burroughs, Andrew K.; Planas, Ramon; Escorsell, Angels; Garcia-Pagan, Juan Carlos; Patch, David; Matloff, Daniel S.; Gao, Hong; Makuch, Robert (2005). “Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis”. New England Journal of Medicine. 353 (21): 2254–2261. doi:10.1056/NEJMoa044456. ISSN 0028-4793.
- ↑ Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, Attili AF, Riggio O (2003). “Incidence and natural history of small esophageal varices in cirrhotic patients”. J. Hepatol. 38 (3): 266–72. PMID 12586291.
- ↑ “Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study”. N. Engl. J. Med. 319 (15): 983–9. 1988. doi:10.1056/NEJM198810133191505. PMID 3262200.
- ↑ D’Amico G, Pagliaro L, Bosch J (1999). “Pharmacological treatment of portal hypertension: an evidence-based approach”. Semin. Liver Dis. 19 (4): 475–505. doi:10.1055/s-2007-1007133. PMID 10643630.
- ↑ Pearlman BL (2006). “Hepatitis C virus infection in African Americans”. Clin. Infect. Dis. 42 (1): 82–91. doi:10.1086/498512. PMID 16323096.
- ↑ Sajja KC, Mohan DP, Rockey DC (2014). “Age and ethnicity in cirrhosis”. J. Investig. Med. 62 (7): 920–6. doi:10.1097/JIM.0000000000000106. PMC 4172494. PMID 25203153.
- ↑ Sajja KC, Mohan DP, Rockey DC (2014). “Age and ethnicity in cirrhosis”. J. Investig. Med. 62 (7): 920–6. doi:10.1097/JIM.0000000000000106. PMC 4172494. PMID 25203153.
- ↑ Pearlman BL (2006). “Hepatitis C virus infection in African Americans”. Clin. Infect. Dis. 42 (1): 82–91. doi:10.1086/498512. PMID 16323096.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
